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Protein oligomerizationThe PIV-5 hemagglutinin-neuraminidase (HN) protein is a multifunctional protein with sialic acid binding,
neuraminidase and fusion promotion activity. HN is internalized by clathrin-mediated endocytosis and
degraded. HN lacks internalization signals in its cytoplasmic tail but a single glutamic acid present at residue
37 at the putative transmembrane/ectodomain boundary is critical. We rescued rPIV-5 with mutations E37D
or E37K, which have been shown to impair or abolish HN internalization, respectively. These viruses
exhibited growth properties similar to wild-type (wt) virus but are impaired for ﬁtness in tissue culture.
Biochemical analysis of HN activities showed differences between HN E37D and HN E37K in fusion
promotion and incorporation of HN and F into virions. Furthermore, oligomeric analyses indicate that HN
E37 mutants perturb the tetrameric organization of HN, probably by destabilizing the dimer-of-dimers
interface.y, Molecular Biology, and Cell
an 2-100, Evanston, IL 60208-
b).
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Paramyxoviruses are enveloped, negative-stranded RNA viruses
that include many clinically and agriculturally important pathogens
such as mumps virus, measles virus, Newcastle disease virus (NDV),
Hendra virus, and Nipah virus. Cellular entry by paramyxoviruses is
mediated by two glycoproteins present at the surface of the virion. For
the paramyxovirus parainﬂuenza virus 5 (PIV-5), these proteins are
the fusion protein (F) and the hemagglutinin-neuraminidase protein
(HN). F mediates the fusion of the viral membrane with the cellular
plasma membrane at neutral pH. Co-expression of the HN protein
enhances this fusion process by lowering the activation energy
required for F to mediate fusion (Russell et al., 2001). In addition to its
fusion promotion activity, HN also functions in binding the virion to
its receptor sialic acid on target cells and possesses receptor-
destroying activity (neuraminidase activity) that cleaves sialic acid
from the surface of both infected cells and virions. This action is
thought to prevent the aggregation of budded virions at the surface of
infected cells. The viral matrix (M) protein is a peripheral membrane
protein that underlies the lipid bilayer and makes contact with the
glycoprotein cytoplasmic tails. The PIV-5 ribonucleoprotein is com-
posed of three proteins: nucleocapsid (NP), phosphoprotein (P), and
the large polymerase (L), which together act to transcribe andreplicate the genome RNA (Lamb and Parks, 2007). Additionally, PIV-5
contains proteins that assist in evasion of host cell immunity: the
small hydrophobic protein (SH), which inhibits tumor necrosis factor
alpha signaling and prevents apoptosis in infected cells (He et al.,
2001; Lin et al., 2003; Wilson et al., 2006) and the V protein that
antagonizes interferon synthesis and signaling (Andrejeva et al.,
2004; Didcock et al., 1999).
PIV-5 HN is a type II integral membrane protein that consists of a
short N-terminal cytoplasmic tail of 17 residues, a hydrophobic
domain of 19 residues that acts as both a signal sequence to target HN
to the ER membrane and as a stop-transfer transmembrane (TM)
domain, a stalk region of 82 residues, and a large globular head (447
residues) that contains both the receptor binding and destroying
activities (Hiebert et al., 1985; Parks and Lamb, 1990). HN exists at the
surface of virus-infected cells as a tetramer, consisting of two
disulﬁde-linked dimers that are linked through non-covalent inter-
actions (Ng et al., 1989). The crystal structure of the full-length
ectodomain of HN has been solved both in the presence and absence
of ligand (Yuan et al., 2005). No electron density was identiﬁed for the
stalk region; however, biophysical data indicates that the stalk adopts
a ﬂexible and rod-like α-helical conformation. Additionally, HN head
domain expressed with the stalk forms a tetramer, whereas
expression of the HN head domain on its own is monomeric. Thus it
is thought that the stalk domain stabilizes the head domain oligomer
(Yuan et al., 2008). The enzymatically active head region of HN
contains the antigenic sites of the protein and has a typical sialidase/
neuraminidase fold, a superbarrel with six antiparallel β strands with
a centrally located active site. The crystal structure data shows that
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between the monomers of 1810 Å2. In contrast, the interface between
the dimer-of-dimers is much smaller, burying only 657 Å2 and
involving 10 residues (Yuan et al., 2005). This suggests that the
dimer-of-dimers interface may be easier to perturb. The interaction
between the dimer-of-dimers interface is not well conserved among
paramyxovirus attachment proteins, and its weaker interaction
energy could be a feature of the process of F activation.
Despite the fact that PIV-5 HN is a major spike glycoprotein of the
buddedvirion, in virus-infected cells PIV-5HNis extensively internalized
fromthecell surfacewhereas F is not internalized and is stably expressed
at the cell surface (Ng et al., 1989). Furthermore, it has been shown that
HN is internalized by clathrin-coated pits and enters the endocytic
pathway (Leser et al., 1996). When HNwas expressed from cDNA using
an SV40-recombinant virus it was found that the rate of HN turnover
from the cell surface was 6.5–7.0%/min, which is faster than the bulk
membrane turnover and comparablewith the rate of other endocytosed
receptors. Analysis by electron microscopy showed that PIV-5 HN
colocalizes with transferrin and gold-conjugated bovine serum albumin,
markers for early endosomal/late endosomal compartments and
lysosomal compartments, respectively (Leser et al., 1996). Furthermore
it was shown by ﬂuorescence microscopy that HN colocalized with
lamp-1, indicating that the lysosome is the subcellular compartment
where internalized HN becomes localized (Leser et al., 1996).
The observation that PIV-5 HN is internalized from the cell surface
was surprising, as the protein lacks a canonical internalization signal in
its cytoplasmic tail. The 17 residue cytoplasmic tail of HN does not
contain a tyrosine-based internalization sequence, nor does it have
other known internalization signals such as a di-leucine, a di-lysine, or a
site for monoubiquitination (Bonifacino and Weissman, 1998; Chen et
al., 1990; Collawn et al., 1990; Hamer et al., 1997; Itin et al., 1995;
Letourneur and Klausner, 1992; Trowbridge et al., 1993). Mutagenesis
experiments showed the cytoplasmic tail of HN is dispensable for
internalization (Leser et al., 1999). Further, a single glutamic acid (E37),
the ﬁrst residue of the ectodomain at the putative TM/ectodomain
boundary, was shown to be critical for HN internalization (Leser et al.,
1999). A series of E37 HN mutants were constructed and expressed in
cells. One of these mutants, E37D, had a rate of internalization and
overall extent of internalization that was signiﬁcantly less than that of
wild-type (wt) HN. Other mutants, such as E37K, were not internalized
above background levels. Reversing the ﬁrst seven amino acids of the
ectodomain was also examined, as was substituting leucine for the
glutamic acid at position 37 and glutamic acid for the leucine at position
43; all of these combinations diminishedHN internalization. Thus itwas
concluded that the presence of a glutamic acid at position 37was critical
for PIV-5 HN internalization (Leser et al., 1999).
We have examined the role of internalization mutants on the
lifecycle of PIV-5 through the rescue of recombinant PIV-5 containing
the mutations HN E37D or E37K. These rescued viruses were greatly
impaired or defective for HN internalization during cellular infection.
We describe the growth characteristics of these viruses together with
an analysis of the enzymatic and receptor binding activities of the
mutated HN proteins. The ability of these E37 mutants to promote F
mediated fusion is also described, and related to ﬁndings regarding
the oligomeric organization and stabilities of these proteins.
Results
HN internalization in virus-infected cells
Previous work has demonstrated that in PIV-5-infected cells, HN is
internalized from the cell surface and degraded by lysosomes (Ng et
al., 1989). Analysis of HN expressed from a recombinant SV40 virus
indicated that internalization of HN was an intrinsic property of the
HN protein, not requiring expression of other PIV-5 proteins (Leser et
al., 1996). It was also found that mutation of the charged residue(E37) that deﬁnes the ectodomain/TM domain boundary largely
abolished internalization (Leser et al., 1996, 1999). To determine if the
HN E37 mutants affected internalization in PIV-5-infected cells, HN
E37D and HN E37K mutations were recovered in PIV-5 virus using a
previously described reverse genetics system (He et al., 1997;Waning
et al., 2002). To detect HN degradation, CV-1 cells were infected with
wt PIV-5 or with mutant HN E37D or HN E37K viruses. The virus-
infected cells were metabolically labeled with [35S]-TranS-label in a
pulse chase protocol followed by immunoprecipitation with a mix of
monoclonal antibodies and analysis of polypeptides by SDS-PAGE.
Two of the antibodies used for immunoprecipitation (HN-1b and HN-
4b) have been shown previously to be conformation speciﬁc (Ng et al.,
1989). Thus, samples taken at 0 time display lower signals than those
samples taken after 1 h because the conformational epitopes had not
fully matured (Fig. 1).
Cells infected with wt virus displayed robust fragmentation of HN,
with degradation products (40 kD and 34 kD) detectable as early as 2
h in the chase period (Fig. 1). By 5 h post-label, approximately 61% of
the detectable HN protein was present as degradation products. In
contrast, cells infected with either PIV-5 HN E37D or HN E37K viruses
did not display high levels of HN degradation. For HN E37D virus-
infected cells, degradation products were barely detectable at 3
h post-label and comprised only 2.7% of detectable HN at 5 h post-
label. Results for HN E37K virus-infected cells were similar with
degradation products comprising less than 1% of all detectable HN at
the 5 h time point. The small difference in HN E37D and HN E37K
degradation mirrors earlier ﬁndings in that the block of HN E37D
internalization is not absolutely complete as compared with HN E37K
internalization, which is indistinguishable from the bulk membrane
turnover (Leser et al., 1999). This analysis shows that mutations at
residue E37 in HN block internalization and degradation of the protein
in the context of virus-infected cells.
To assess further the stability of HN E37D and HN E37K at the cell
surface protein synthesis was inhibited in virus-infected cells at 18 h
p.i. by treatment with cycloheximide to prevent transport of newly
synthesized HN to the cell surface. At 0 or 4 h after cycloheximide
treatment, cells were ﬁxed and labeled using either HN-1b to detect
HN or F1a to detect the F protein, and stained using an Alexa Fluor
488-conjugated secondary antibody. At the t=0 time point, HN
staining was widespread at the surface of the infected cells and there
was no detectable staining above background for the mock infected
cells (Fig. 2). After 4 h of cycloheximide treatment there was less HN
present on the surface of the infected cells, though HN protein was
detectable (Fig. 2). This is consistent with the immunoprecipitation
experiments shown above that indicated that about half of wt HN
protein in PIV-5-infected cells was still present in its full-length form
at 4 h post-labeling (Fig. 1). This is also consistent with the data
obtained in ﬂow cytometry experiments (Fig. 3). In contrast, cells
infected with PIV-5 HN E37D or HN E37K virus did not display a
decrease in HN staining (Fig. 2). This indicates HN E37D and HN E37K
proteins are stably expressed at the surface of infected cells for at least
4 h. PIV-5 F proteinwas stably expressed at the cell surface conﬁrming
earlier data (Leser et al., 1996; Ng et al., 1989). This experiment also
demonstrates that the stability of HN protein on the cell surface does
not affect the stability of F on the cell surface when HN and F are
present together in virus-infected cells.
The surface expression level of HN E37D and HN E37K in PIV-5-
infected cells was also analyzed by ﬂow cytometry. CV-1 cells were
infected for 18 h and treated with cycloheximide as described above.
Following cycloheximide treatment for either 0 or 4 h, cells were ﬁxed
and stained for either HN or F proteins using either a polyclonal HN
antibody or mAb F1a and then analyzed by ﬂow cytometry. The
results were expressed as a percentage of the mean ﬂuorescence
intensity of the wt HN staining at t=0. Fig. 3 shows that at the 0
h time point there is ~50% more HN E37D and E37K present on the
surface on virus-infected cells when compared to wt virus-infected
Fig. 1. Stability of HN E37D and HN E37K in PIV-5-infected cells. CV-1 cells were
infected with wt PIV-5 or PIV-5 HN E37D or HN E37K and at 18 h p.i. were labeled with
[35S]-TranS-label for 30 min (pulse), the label removed and the cells incubated in
DMEM for varying periods ranging from 0 to 5 h. Cells were lysed in lysis buffer and
proteins immunoprecipitated with a mix of HN monoclonal antibodies and polypep-
tides analyzed by SDS-PAGE as described in Materials and methods. The time of chase
period is indicated above each lane in hours.
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PIV-5-infected cells had decreased ~50%. In comparison, there were
similar ﬂuorescence intensities of HN E37D and HN E37K present at
both the 0-h and 4-h time points (Fig. 3). Flow cytometry also showed
that there were similar percentages of virus-infected cells for all
viruses used. Parallel experiments were conducted to determine thelevel of F staining in either wt or E37 mutant virus-infected cells. The
data demonstrated that the F protein was stable in virus-infected cells
after 4 h of cycloheximide treatment (data not shown).
Growth properties of viruses containing HN E37D and E37K mutations
To determine the growth rate for rPIV-5 viruses containing
mutations at residue E37, MBDK cells were infected at a MOI of 0.01
PFU/cell and cell culturemediumwas harvested every 24 h for 6 days.
As shown in Fig. 4A, growth of the E37 mutants was indistinguishable
from wt PIV-5 with the exception of the 24 h time point, at which the
wt virus displayed a titer that was one log higher than either of the
two mutant viruses.
To analyze further the growth of the E37 PIV-5mutants, the plaque
morphology in BHK-21 cells of each of the mutant viruses was
compared to that of wt virus (Fig. 4B). The size and shape of rPIV-5 HN
E37D and rPIV-5 HN E37K plaques were similar to those formed in wt
PIV-5 virus-infected cells. These data indicate that rPIV-5 HN E37D
and rPIV-5 HN E37K have similar growth properties to wt virus.
Fitness assay of viruses containing HN E37D and E37K mutations
To determine whether the decrease or lack of HN internalization
in rPIV-5 HN E37D and rPIV-5 HN E37K infected cells had an effect
on the ﬁtness of the virus when compared to wt PIV-5, the mutant
E37 viruses were competed against wt PIV-5 in a series of sequence-
based viral ﬁtness competition assays. This method is based on one
used to analyze mutants of vesicular stomatitis virus (Novella et al.,
2004). To study the ratio of mutant virus RNA to wt virus RNA using
nucleotide sequencing, a series of standards was developed using
plasmid DNAs containing the HN cDNA. Different ratios (weight to
weight) of pSV103 plasmid containing the coding region for either
the full-length, wt HN or either one of the E37D or E37K mutations
(Leser et al., 1999) were mixed together and sequenced using a
primer that would cover the nucleotides corresponding to residue 37
in the HN protein. The electropherogram peaks corresponding to
each of the mutations and the wt nucleotides (GAG-NGAC for E37D
and GAG-NAAG for E37K) were measured and expressed as a ratio of
the height of the mutant peak over the height of the wt peak. This
experimentally determined peak ratio was plotted against the actual
ratio of mutant to wt plasmid added to the reaction. The resultant
graph was used to ﬁt a line, the equation of which could be used to
determine the ratio of mutant to wt virus in sequencing reactions of
cDNA derived from viral RNA isolated from the cell culture super-
natants of virus-infected cells. Fig. 5A and B show the sequencing
standard curves for HN E37D:wt and HN E37K:wt, respectively. The
straight line describes the best ﬁt for the measured data (R2=0.99
for E37D:wt and R2=0.96 for E37K:wt).
To assess the ﬁtness of the mutants compared to wt virus, two
different approaches were used. In the ﬁrst, either rPIV-5 HN E37D
and wt rPIV-5 or rPIV-5 HN E37K and wt rPIV-5 were used to infect
MDCK cells at a mutant:wt ratio of 20:1. Additionally, cells were
infected individually with wt rPIV-5, rPIV-5 HN E37D, or HN E37K
viruses to check that the virus sequence was stable over the time
course of the experiment. Three days p.i., the cell culture supernatant
was used to infect a fresh plate of MDBK cells. At the same time, viral
RNAwas isolated from the supernatant and used to derive cDNA using
reverse transcription followed by PCR. The resulting amplicon was
subjected to sequencing using the same primer that was used to
sequence the plasmids in order to make the standard sequencing
curves. This process was repeated for four cycles. Fig. 5C shows
examples of electropherograms generated by this process. For each
electropherogram, the heights of the mutant and wt peaks were
measured. The equation derived from the sequencing standards was
then used alongwith the ratio of themeasured peaks to determine the
ratio of mutant to wt vRNA present in the cell culture supernatant at
Fig. 2. Cell surface ﬂuorescence of wt HN and E37 mutants in PIV-5-infected cells. PIV-5-infected CV-1 cells at 18 h p.i. (0 h) were incubated with 100 μg/ml cycloheximide to inhibit
protein synthesis. At either 0 or 4 h, cells were ﬁxed for indirect ﬂuorescence staining and bound with antibodies speciﬁc for either HN (MAb HN-1b) or F (MAb F1a) and then with
Alexa Fluor 488-conjugated goat anti-mouse secondary antibody. Fluorescence was detected using a Zeiss Axiovert 200 Mmicroscope with Apotome. The top two rows showHN cell
surface staining at 0 and 4 h post-treatment, respectively; the bottom two rows show F cell surface staining at 0 and 4 h post-treatment, respectively. Bar, 10 μm.
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and HN E37K with wt virus, the ratio of mutant to wt remained
unchanged at roughly 20:1. However, by p2 the ratio of mutant to wt
present in the cell culture supernatants began to decrease. By passage
4, the mutant to wt ratio was nearly 1:1 for HN E37D:wt and had
decreased to ~1:3 for HN E37K:wt. The decrease in the mutant to wt
virus ratio for each virus is graphed in Fig. 5D. The relative ﬁtness of
each mutant virus is expressed as the slope of the line that describes
the change in ratio in each passage. The relative ﬁtnesses of the
mutant viruses are −0.29 and −0.33 for HN E37D and HN E37K,
respectively.
In the second approach to analyzing viral ﬁtness, MBDK cells were
infected as above at a 100:1 mutant to wt ratio. Instead of passaging
the virus every 3 days, in this experiment MDBK cells were allowed to
remain infected for 8 days. MDBK cells can be infectedwith PIV-5withFig. 3. Detection of wt HN and E37 mutant HNs at the surface of infected cells by ﬂow
cytometry. (A) PIV-5-infected CV-1 cells at 18 h p.i. (0 h) were incubated with 100 μg/
ml cycloheximide to inhibit protein synthesis. At either 0 or 4 h, cells were ﬁxed for
indirect ﬂuorescence staining and boundwith antibodies speciﬁc for either HN (HN-1b)
or F (F1a) and then with a ﬂuoroscein-isothiocyanate-conjugated secondary antibody.
The mean ﬂuorescence intensity (MFI) of each sample is expressed as a percentage of
the MFI of wt HN at 0 h.minimal cytopathic effects for long periods of time (Choppin, 1964).
At days 5, 6, 7 and 8 days p.i., a small aliquot of cell culture
supernatant was removed from the cell culture dish. vRNA was
isolated from the supernatant, and cDNA and amplicons for
sequencing were prepared as described above. In this experiment,
the mutant to wt ratio dropped from 100:1 to 2.1:1 and 4.9:1 for HN
E37D and HN E37K, respectively (Fig. 5E). In a similarly designed
experiment that lasted for 11 days, the mutant to wt ratio dropped
from 100:1 to 2:1 and 4:1 for HN E37D and HN E37K, respectively
(data not shown). Taken together, these assays indicate that the HN
E37D andHN E37K viruses are less ﬁt as compared towt virus in tissue
culture cells despite having similar growth properties when com-
pared in a multi-step growth curve and by plaque morphology.
As a basis of comparison and as a veriﬁcation of the technique, a
virus that displays a severe growth defect was competed against wt
virus in a ﬁtness assay. PIV-5 HN Δ2–13 contains a deletion of 12
amino acids of the HN cytoplasmic tail and has been characterized
previously (Schmitt et al., 1999). This virus is replication impaired as
judged by its small plaque size, reduced replication rate, and lowered
maximum titers when compared with wt PIV-5 virus. Sequencing
electropherogram standards were constructed as described above.
PIV-5 HNΔ2–13 was co-cultivated at a ratio of 100:1 with wt virus. By
day 4, the mutant to wt ratio had dropped to 1:1 and by day 7 the wt
had outcompeted the mutant and was present at a 1:5 mutant to wt
ratio (data not shown). Thus, the data indicate that the loss of ﬁtness
for HN E37D and HN E37K is a subtle loss as compared to the major
loss of a greatly impaired mutant virus.
E37 mutations affect the composition of PIV-5 virions
To investigate if the HN mutations affected virion composition, wt
PIV-5 virus, HN E37D, and HN E37K viruses were grown in MDBK cells
and virions puriﬁed. The polypeptide composition of the virions was
Fig. 4. Growth kinetics and plaque formation of PIV-5 HN E37 mutants. (A) Growth
curves of PIV-5 E37 mutants. MDBK cells were infected at an MOI of 0.01 pfu/cell and
the culture media harvested at various times p.i. Titers at each time point are the
average of triplicate experiments. (B) Morphology of plaques formed in BHK-21F PIV-5-
infected cells at 4 days p.i.
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The virions contained abundant amounts of HN, NP, F1/F2, P, and M.
Viral proteins V, L, and SH were not readily visible by silver staining.
The HNmutant viruses had similar compositions to wt virus, with the
exception of the amount of F in the PIV-5 HN E37D virus as F1/2 were
present in more abundant amounts as compared to wt PIV-5.
To investigate further this ﬁnding, [35S]-methionine-labeled
virions were prepared for wt PIV-5, HN E37D and HN E37K viruses
(Fig. 6B). The polypeptides of the virions were analyzed by SDS-PAGE
and radioactivity quantiﬁed using Multigauge software. The abun-
dance of each protein present in the virions was calculated based on
2541 NP proteins per genome RNA (Lamb and Parks, 2007), the
known number of methionines in each protein and the quantiﬁed
radioactivity per protein (Table 1). When compared with wt virus,
both PIV-5 HN E37D and HN E37K have similar overall amounts of M
protein. However, HN E37D virions have ~68% of the number of HN
tetramers as wt virions. The differences for F trimers are even more
dramatic; HN E37D virions contain 1.6 times the amount of F as
compared to wt virions, conﬁrming the results obtained from silver
staining of virus. There were also differences observed for PIV-5 HN
E37K virions, though they were not as large. HN E37K virions
contained about 89% of the HN tetramers as wt virus, and slightly
more F trimers. Overall, these changes affected the ratios of the
glycoproteins on the surface of virions. For wt PIV-5 virions, HN and F
were present at a 1.6:1 ratio. In contrast, for HN E37D and HN E37Kthe ratios were 0.7:1 and 1.3:1, respectively. These results suggest
that mutations present at residue 37 of HN affect the recruitment of
the surface glycoproteins into budding virions. These data also imply
that the ratio of HN to F on the surface of virus-infected cells is not
maintained in the budded virion (data not shown and Table 1),
indicating that the virus preferentially recruits wt HN into the virion.
Analysis of HN neuraminidase and hemadsorption activities
As neuraminidase activity is required to prevent aggregation of
virus on budding at the plasma membrane the neuraminidase activity
of puriﬁed wt PIV-5 viruses and HN E37D and HN E37K was tested
(Fig. 7A). It was found that whereas HN E37D and wt virions have
similar neuraminidase activities when compared by overall amounts
of virus added to the enzymatic reactions, when the amount of HN
tetramers in the preparations was taken into consideration HN E37D
has a neuraminidase activity that is over double that of wt HN
(p=0.0009). In comparison, PIV-5 HN E37K has a similar activity to
wt HN virus (~130% of wt, p=0.09). The kinetics of neuraminidase
activity was also tested and the HN mutants were found to have very
similar kinetics to that of wt HN (Fig. 7B).
To determine if there is an effect of the E37 mutations on the
receptor binding capability of the HN protein, a hemadsorption assay
was used. CV-1 cells were infected with wt PIV-5 or the HN E37
mutants and at 18 h p.i. were incubated with chicken erythrocytes for
1 h at 4 °C using two pHs, pH 7.0 and pH 5.0. pH 7.0 is similar to the
extracellular environmentwhere receptor binding takes place, and pH
5.0 is close to the pH optimum for the neuraminidase activity of the
HN protein (Merz et al., 1981). Comparison of the receptor binding
activities of HN showed little difference between wt HN or either HN
E37D or HN E37K at either pH (Fig. 7C).
Analysis of HN fusion promotion activity
To investigate if E37mutations impact the ability of HN to promote
fusion, BHK-21 cells were transfected with a plasmid expressing PIV-5
F and plasmids expressing wt HN, HN E37D, or HN E37K. Cells co-
expressing wt HN and F displayed robust syncytia formation (Fig. 8A).
In contrast, cells that co-expressed F and HN E37D displayed syncytia
formation, but not as extensively as wt HN and F transfected cells.
Cells co-expressing HN E37K and F showed large syncytia formation
with extensive cytopathic effects. To quantify these results, the HN
E37 mutants were compared to wt HN in a luciferase reporter assay.
The results shown in Fig. 8B parallel those obtained in the syncytia
assay. Co-expression of F and HN E37D only caused 13.7% percent of
wt HN and F fusion. Co-expression of F and HN E37K caused a fusion
activity of 171% of wt HN and F fusion. To ensure that F and HN were
properly expressed, Vero cells were transfected with PIV-5 F and wt
HN and E37 mutants in parallel to the luciferase assay and examined
for protein expression by immunoprecipitation. HN E37D and HN
E37K were expressed properly in the Vero cells used for luciferase
reporter assays (Fig. 8C, left panel). Additionally, wt F was expressed
at similar levels when co-transfected with HN constructs in Vero cells
(Fig. 8C, right panel). This rules out the notion that the syncytia and
luciferase reporter data are a result of differential expression of HN
and F in co-transfected cells.
Mutations at E37 affect HN oligomerization
Membrane bound HN and soluble HN consisting of the stalk and
head domain is tetrameric. In contrast, the expressed head domain is
monomeric (Ng et al., 1989; Russell et al., 2001; Yuan et al., 2005). The
HN tetramer consists of a dimer-of-dimers, with each pair of dimers
linked covalently by an interchain disulﬁde bond at residue C111. The
X-ray structure of HN shows that the dimer-of-dimers interface is
weak (657 Å2), stabilized by non-covalent interactions involving only
Fig. 5. Viral ﬁtness of PIV-5 HN E37 mutants compared to wt PIV-5 in tissue culture. (A) Sequencing standards for HN E37D versus wt HN. Plasmids encoding wt HN and HN E37D
were mixed together in various ratios (by plasmid weight) and sequenced. The height of the mutant peak compared to the wt peak on each chromatogram was plotted against the
ratio of the plasmid added to the assay and graphed. (B) Sequencing standards for HN E37K versus HN were prepared as described in (A). (C) Sequencing chromatograms of E37
codon for PIV-5 HN E37D and HN E37K versus wt PIV-5 at each infection passage of the passage-based ﬁtness assay. MBDK cells were infected at a mutant to wt virus ratio of 20:1. At
72 h p.i., the media were harvested and used to infect a fresh plate of MBDK for three additional passages. Viral RNA was isolated from each medium collection. The viral RNA was
reverse transcribed and sequenced over the E37 position. The relative heights of the chromatogram peaks at each mutation point were used to determine the ﬁnal ratio of PIV-5 HN
E37 mutant virus to wt virus present after each passage, based on the sequencing standards. (D) Quantiﬁcation of ﬁtness of PIV-5 HN E37D and HN E37K mutants versus wt PIV-5 at
each passage number. The ratio of mutant to wt virus after each passage was expressed as a percentage of the original infection ratio and plotted. The slope of the line describes the
relative ﬁtness of each PIV-5 HN E37 mutant compared to wt virus. (E) Sequencing chromatograms of E37 codon for PIV-5 HN E37D and HN E37K versus wt PIV-5 at each time point
in the time course ﬁtness assay. MDBK cells were infected with PIV-5 at a mutant to wt ratio of 100:1. At the various time p.i. viral RNA was isolated from the medium, reverse
transcribed, and sequenced as described in Materials and methods.
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organization, metabolically labeled infected cells were subjected to
sucrose gradient density centrifugation in 0.1% Triton X 100. Alternate
fractions of the gradient were analyzed by immunoprecipitation and
non-reducing SDS-PAGE. HN from wt virus-infected cells sedimented
primarily at the dimer-of-dimers position on the gradient (Fig. 9A,
left, lanes 17 and 19). A small amount of wt HN was also present in
monomer and dimer fractions. In contrast, HN E37D sedimented
primarily as a dimer (Fig. 9A, middle, lanes 13 and 15), with a smallerpopulation existing in the dimer-of-dimers fractions (Fig. 9A, middle,
lanes 17 and 19). HN E37K also sedimented as a dimer on the sucrose
gradient (Fig. 9A, right, lanes 13 and 15). Thus, these data suggest HN
E37D and HN E37K both exist primarily as dimers. To ascertain if
mutations at E37 prevent the HN tetramer from being formed or
simply destabilize the dimer-of-dimers interface such that the
tetrameric form of the protein falls apart during centrifugation or on
exposure to detergent, we investigated the oligomerization of HN in
different detergents using blue native PAGE of puriﬁed virions
Fig. 6. Protein composition of rPIV-5 virions containing HN E37mutations. (A)Wt PIV-5
and E37 mutant virions were grown in MBDK cells and puriﬁed on sucrose density
gradients as described in Materials and methods. Virion polypeptides were analyzed by
SDS-PAGE and by silver staining. (B) Polypeptides from [35S]-methionine-labeled
virions were analyzed by SDS-PAGE. Radioactivity was quantiﬁed on a Fuji FLA-5100
Imager and using MultiGauge v3.0 software.
Fig. 7. Receptor destroying and receptor binding activity of HN E37 mutants.
(A) Neuraminidase activity of puriﬁed PIV-5 virions. Puriﬁed virions were mixed
with N-acetylneuraminyl lactose at pH 4.5 for 1.5 h at 37 °C. Cleaved substrate was
detected using a colorimetric assay as described in Materials and methods and the
absorbance read at 549 nm. Each average is the result of ﬁve experiments and is
normalized to the amount of HN present in puriﬁed virions. (B) Neuraminidase kinetics
of puriﬁed PIV-5 virions. Puriﬁed virions were treated as described in (A) and the
amount of cleaved substrate present at various time points was determined by
colorimetric assay. (C) Hemadsorption of PIV-5-infected cells. PIV-5-infected CV-1 cells
at 18 h p.i. were incubated for 30 min with a 1% suspension of chicken red blood cells
(RBCs) in PBS at pH 5.0 or pH 7.0. Bound RBCs were lysed and the absorbance of the
lysed RBCs read at 410 nm.
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E37D, and HN E37K were all present primarily as tetramers (T) and
higher order molecular weight oligomers (Fig. 9B, left lanes).
However, HN E37D and HN E37K were also present as dimers (D)
whereas wt HN was tetrameric. These data suggest that both mutant
HN proteins are capable of forming tetramers, but these mutant
oligomers fall apart more readily upon exposure to detergent. The
effect of other detergents was also investigated. Treatment with
Triton X-100 changed the oligomeric state of all three proteins tested,
with a majority of the proteins present in either the dimeric or
tetrameric form (Fig. 9B, right lanes). However, there were subtle
differences exhibited among the proteins. Higher molecular weight
oligomers of HN E37D appeared to be resistant to detergent, whereas
those present in wt HN and HN E37K were not. Additionally, there
appeared to be some other species of HN present for HN E37D and HNTable 1.
Abundance of F, HN and M proteins in virions.
HN Wt HN E37D HN E37K
HN Tetramers 629 425 559
F Trimers 389 635 440
M 5031 4904 5005
HN/F Ratio 1.62 0.67 1.27
To calculate the relative abundance of the F, HN and M proteins in virions [35S]-
methionine-labeled virions were prepared for wt PIV-5, HN E37D and HN E37K viruses
(Fig. 6B). The polypeptides of the virions were analyzed by SDS-PAGE and radioactivity
was quantiﬁed using a Fuji BioImager and Multigauge software. The abundance of each
protein present in the virions was calculated based on 2541 NP proteins per genome
RNA (Lamb and Parks, 2007), the known number of methionine residues in each
protein and the quantiﬁed radioactivity per protein. F and HN are calculated as trimers
and tetramers to yield the average number of each spike glycoprotein per virion.E37K, indicating that the mutant monomers may mediate unique
protein–protein contacts as compared to wt HN. Thus, mutations
present at E37 perturb the structure of HN.
Analysis of the stalk: The HN tetramerization domain
It has been reported previously that the HN stalk (residues 56–
115) is a tetramer in solution (Yuan et al., 2008). Based on the results
of the oligomerization of the full-length wt HN protein and the E37
mutants, we were interested to determine if the E37 mutants
impacted the oligomerization and secondary structure of the HN
stalk. We expressed HN stalk residues 34–115 containing an N-
terminal 6X His-tag in bacteria and puriﬁed the stalk as described in
Materials and methods. The E37K stalk construct was very poorly
expressed and is not considered further. Initially, the N-terminal His-
Fig. 8. Fusion promotion activity of HN E37 mutants. (A) Representative micrographs of syncytia formed in BHK-21F cells expressing PIV-5 F and either wt HN or HN E37 mutants at
18 h p.i. (B) Luciferase reporter assay of cell–cell fusion. Vero cells were transfected with an expression plasmid for PIV-5 F and a plasmid expressing luciferase under the control of a
T7 promoter together with wt HN or one of the HN E37mutants. At 18 h p.t., cells were overlaid with the T7 polymerase expressing BSR-T7/5 cells and incubated for an additional 6 h
and luciferase activity measured. The assay was performed in triplicate and the data expressed as a percentage of the fusion promoted in the presence of wt HN. (C) Expression of
PIV-5 HN and F in Vero cells. Vero cells were transfected with an expression plasmid for PIV-5 F and a plasmid expressing luciferase under the control of a T7 promoter together with
wt HN or one of the HN E37 mutants. At 18 h p.t., cells were radiolabeled for 30 min with [35S]-TranS-label and then incubated for 1.5 h with unlabeled media. Cells were lysed and
proteins were immunoprecipitated with either a polyclonal HN antibody or F antibody and separated using SDS-PAGE as described in Materials and methods.
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However, this made the stalk peptides more susceptible to proteolytic
degradation even after gel ﬁltration. It was found that the protein
yield and stability was increased greatly by omitting the enterokinase
cleavage step. Fig. 10A shows puriﬁed wt and E37D stalk constructs.Fig. 9. Oligomerization of PIV-5 HN. (A) Sucrose density ultracentrifugation of PIV-5 HN from
TranS-label and then incubated for 1.5 h in unlabeled medium. The cells were lysed in Triton
19 h at 37,000 rpm. Fractions were collected from the top of the gradient. Alternating fracti
SDS-PAGE. Wt HN- left panel, HN E37D- middle panel, HN E37K- right panel. (B) Blue nativ
digitonin or Triton X-100 were fractionated by BN-PAGE on a 4–13% gel using crosslinked
polyvinylidene diﬂuoride membrane in the presence of SDS and probed with a polyclonal
secondary antibody. Fluorescence was detected on a Fuji FLA-5100 imager. D=dimer; T=Circular dichroism spectroscopy was used to investigate the second-
ary structure of the HN stalk peptides. The spectra were analyzed
using the computer program CDSSTR and it was determined that the
resulting structural data were of good quality (NRMSDb0.1). Wt
stalk and E37D stalk displayed similar CD spectra that were typical ofinfected cells. PIV-5-infected CV-1 cells at 18 h p.i. were labeled for 30 min with [35S]-
X-100 and subjected to ultracentrifugation on a 7.5–22.5% wt/vol sucrose gradient for
ons were immunoprecipitated for HN using a polyclonal HN antibody and analyzed by
e PAGE (BN-PAGE) of puriﬁed PIV-5 virions. Puriﬁed PIV-5 virions solubilized in either
glutamate dehydrogenase as a size marker. Separated proteins were transferred to a
antibody speciﬁc to HN followed by the addition of a Cy5-conjugated goat anti-rabbit
tetramer.
Fig. 10. Expression and secondary structure of HN stalk constructs. (A) SDS-PAGE
analysis of HN stalk constructs (residues 34–115) for HN wt and HN E37D. Samples
were either not reduced (left lanes) or reduced (right lanes). (B) Representative CD
spectra of HN wt and HN E37D stalk. (C) Differential scanning ﬂuorimetry of HNwt and
E37D stalk. HN stalk was mixed with SYPRO Orange and subjected to a temperature
gradient of 25-90 °C. Fluorescence was measure using a Bio-Rad iCycler iQ Real-Time
PCR Detection System. Shown is the negative ﬁrst derivative of the Tm curve.
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revealed that both wt stalk and HN E37D stalk had similar secondary
structure contents (α-helical contents of 0.83 and 0.84, respectively).
To determine the stability of each of the HN stalk constructs,
differential scanning ﬂuorimetry was used to monitor the thermal
unfolding of each of the polypeptides. The increase in ﬂuorescence of
SYPRO Orange, a dye with afﬁnity for hydrophobic parts of a protein,
was obtained as the temperature of the stalk peptides was raised from
25 to 95 °C. The melting point was obtained by determining the
minimum of the negative ﬁrst derivative of the raw ﬂuorescence datafrom the melting curve. The melting points of wt and E37D stalk were
found to be 62.5 °C and 61.7 °C, respectively (Fig. 10C). Thus, both wt
and E37D stalk constructs have similar thermal stabilities.
Discussion
It has been demonstrated previously that the HN protein of PIV-5
is rapidly internalized from the surface of cells through clathrin-
mediated uptake and enters the endocytic pathway, where it is
rapidly degraded (Leser et al., 1996; Ng et al., 1989). The cytoplasmic
tail of PIV-5 HN lacks a known canonical signal for internalization and
deletion of the cytoplasmic tail does not affect endocytosis. Studies
have shown that the signal for HN internalization resides in the ﬁrst
seven amino acids of the presumptive ectodomain of the protein; a
glutamic acid (E37) located at the transmembrane domain/ectodo-
main boundary was shown to be critical for internalization (Leser et
al., 1999). Mutation of E37 to aspartic acid (E37D) led to an inter-
nalization phenotype that was intermediate when compared with wt
HN, both in the rate and extent of uptake from the cell surface,
whereas mutation of E37 to other residues (e.g. E37K) resulted in a
loss of the internalization phenotype.
Our previous studies have used HN expression from viral vectors
(SV40) or plasmid cDNA. To elucidate the role of E37 of PIV-5 HN in
the context of a native viral life cycle, recombinant PIV-5 viruses that
contained either the mutation HN E37D or HN E37K were rescued
using a reverse genetics system (He et al., 1997; Waning et al., 2002).
A detailed study of properties of these viruses was performed.
In comparison to wt HN that is internalized and degraded, HN
expressed by the recombinant viruses HN E37D and HN E37K were
stable in pulse chase experiments and greater amounts of HN E37D
and HN E37K were expressed at the plasma membrane than wt HN.
However, the single-step growth curves of the HN E37D and HN E37K
viruses were very similar to that of wt PIV-5 with the exception of the
24 h time point when PIV-5 showed about 1 log greater infectivity.
Unlike a PIV-5 mutant that is greatly debilitated in growth, such as
HNΔ2–13 that contains a deletion of the HN cytoplasmic tail (Schmitt
et al., 1999) and forms small fuzzy plaques, the PIV-5 HN E37D andHN
E37K viruses yielded wt plaque morphology and size. Fitness assays
showed that PIV-5 HN E37D and HN E37K were biologically less ﬁt in
tissue culture thanwt virus, although the loss ofﬁtness of these viruses
was only subtle in comparison to a greatly debilitated virus, HNΔ2–13.
There is not a useful animal model to study the pathogenicity of PIV-5
and thus it is unknown whether PIV-5 HN E37D and HN E37K would
exhibit a much greater loss of ﬁtness in an animal model.
Investigation of biochemical properties of PIV-5 HN E37D and HN
E37K showed different phenotypes of the two HNmutants. Analysis of
the puriﬁed virion polypeptide composition showed that PIV-5 HN
E37D incorporated fewer HN tetramers into virions than wt virions
(Table 1) but concomitantly incorporated an increased amount of F
trimers. PIV-5 HN E37K had slightly less HN tetramers in virions than
wt virus and had slightly more F trimers. Thus, for HN E37D despite
high levels of HN expression at the cell surface, less HN becomes
assembled into budded virions. Neuraminidase activity, based on the
number of HN tetramers per virion showed that PIV-5 E37D exhibited
a 2-fold higher level of activity than wt virus whereas PIV-5 E37K had
a similar level of neuraminidase activity to wt virus. Receptor binding
(hemadsorption) activity for the HN E37D and HN E37K viruses was
equivalent but given the difference in HN tetramers on the surface of
the cell, the assay may be affected by steric hindrance of the bulky red
blood cells used to measure hemadsorption. Fusion activity of PIV-5
HN E37D was impaired in a reporter-based fusion assay, whereas that
of HN E37 K had increased over wt HN. However, there is more HN
E37K expressed at steady-state on the surface of cells than wt HN due
to its lack of internalization. It has recently been demonstrated that
increased amounts of HN protein present in concert with the F protein
increases the amount of cell to cell fusion observed, thus it is likely
198 J.G. Robach, R.A. Lamb / Virology 406 (2010) 189–201that the increase in fusion observed with HN E37K is due to this fact
(Connolly et al., 2009).
The effect of the mutations on the biochemical properties of HN
E37D and HN E37K does not lead to a simple explanation. However, it
seems possible that the mutations which are located at the presumed
junction of the stalk and the transmembrane (TM) domain affect the
stability of the HN tetramer. Consistent with this is the observation
that HN E37D and HN E37K migrate as tetramers and some dimers on
blue native gel electrophoresis using digitonin as detergent, but when
Triton X-100 was used as detergent HN E37D and HN E37K showed
more dimer formation. Similarly in an analysis of the sedimentation
pattern of wt HN, HN E37D and HN E37K on sucrose gradients
containing 0.1% Triton X-100 as detergent, whereas wt HN sedimen-
ted as a tetramer (dimer-of-dimers), the two mutant HN molecules
sedimented predominantly as a dimer. Taken together these data
suggest that the HN E37D and HN E37K mutations have an effect on
the stability of the tetramer, which is observed on detergent
solubilization of HN. The effect on stability of the HN tetramer may
not be identical for HN E37D and HN E37K as it was observed that
there are differences in the amounts of dimer and tetramer between
mutants (Fig. 9A and B). These subtle differences could lead to the
differences in the biochemical properties of the mutants.
It has been found previously that mutations in the HN TM domain
affect the stability of the HN tetramer. Substitution of serine at residue
31 with residues having bulky side chains led to HN sedimenting as a
dimer (Parks and Pohlmann, 1995). Further mutation of HN tyrosine
residue 36 also resulted in an HN protein that sedimented as amixture
of dimers and tetramers (Parks and Pohlmann, 1995). Thus, mutations
in the HN TM domain and the TM domain–ectodomain boundary
affect the stability of the tetramer.
It has been found that the HN stalk domain (residues 56–115)
forms a tetramer and is predominantly α-helical (Yuan et al., 2008).
Analysis of an HN stalk containing the E37D mutation did not show a
difference in α-helicity or thermal stability. However, if the stalk is a
dimer-of-dimer of helices that do not form a four-helix bundle, then a
decrease in stability of the oligomer may not be detected in the
absence of the ectodomain and TM domain.
The mechanism by which the HN is internalized via clathrin-
coated pits is not known.We speculate that the HN stalk is recognized
by a cellular protein that contains an internalization signal and acts as
an adaptor for internalization. In this scenario we propose that the HN
E37 mutations affect the recognition of the adaptor protein hence
preventing internalization.
Materials and methods
Cells, virus, and plasmids
CV-1, MDBK, and Vero cells were maintained in Dulbecco's
modiﬁed Eaglemedium (DMEM) supplementedwith 10% fetal bovine
serum (FBS). BHK-21 cells were maintained in DMEM supplemented
with 10% FBS and 10% tryptose phosphate buffer. HeLa-CD4-LTR-βgal
cells were grown in DMEM containing 10% FBS, 200 μg/ml G418,
100 μg/ml hygromycin B, and 20 mM HEPES (pH 7.4). BSR T7/5 cells
were maintained in DMEM containing 10% FBS, with the addition of
500 μg/ml G418 every third passage. PIV-5 (isolate W3A) was grown
in MDBK cells. Recombinant PIV-5 viruses were obtained using a
reverse genetics system described previously (He et al., 1997;Waning
et al., 2002). Viral titers were determined by plaque assay on BHK-21
cells. Expression plasmids pCAGGS-HN and pCAGGS-F have been
described previously (Paterson et al., 2000). pCAGGS-HN mutants
were constructed by four-primer PCR followed by cloning into
pCAGGS. The nucleotide sequence of HN in all plasmids and recovered
viruses was veriﬁed using an Applied Biosystems 3100-Avant
automated DNA sequencer (Life Technologies Corp., Carlsbad, CA).
pT7-luciferase was obtained from Promega Corp. (Madison, WI).Expression of HN and F proteins
CV-1 cells were infectedwith PIV-5 in DMEM containing 1% bovine
serum albumin (BSA) at a multiplicity of infection (MOI) of 3 plaque
forming units (PFU) for 1 h in 3.5 cm or 6 cmdishes at 37 °C. Following
incubation, the infection medium was replaced with DMEM con-
taining 2% FBS and returned to 37 °C for an additional 18 h. For
transfections, pCAGGS-HN, pCAGGS-F, and pT7-luciferase were
expressed in BHK-21F or Vero cells seeded in 3.5 cm dishes using
the Lipofectamine PLUS system(Invitrogen, Carlsbad, CA) inOptiMEM.
Vero cells were incubated for 4 h, after which themediawere replaced
with DMEM containing 2% FBS and incubated for an additional 18 h.
Immunoprecipitation and SDS-PAGE
Infected or transfected cells were starved in cysteine and
methionine deﬁcient DMEM for 1 h, followed by labeling with
50 μCi [35S]-TranS-label in the same medium for 30 min. Cells were
then incubated (chased) for the indicated amounts of time in
complete DMEM supplemented with 2 mM methionine and cysteine.
Cells were lysed in cold radioimmunoprecipitation assay (RIPA) buffer
(Paterson and Lamb, 1993) containing protease inhibitors, 50 mM
iodoacetamide, and 2 mM PMSF and clariﬁed in a Beckman TLA100 at
55,000 rpm for 10 min at 4 °C. Clariﬁed lysates were incubated with
the appropriate antibody overnight at 4 °C, followed by the addition of
protein A sepharose beads for 30 min at 4 °C. Antigen–antibody
complexes were washed three times with RIPA containing 0.3 MNaCl,
two times with RIPA containing 0.15 M NaCl, and once with 50 mM
Tris–HCl, pH 7.4, 0.25 mM EDTA, and 0.15 M NaCl. Proteins were
boiled in protein lysis buffer containing 2.5% dithiothreitol and
separated on 15% acrylamide gels. Detection and quantiﬁcation of
radioactivity was performed using a Fuji FLA-5100 with Multi Gauge
v3.0 software (Fuji Medical Systems, Stamford, CT).
Fluorescence microscopy
CV-1 cells seeded on coverslips in 3.5 cm dishes were infected with
PIV-5 at an MOI of 3 PFU/cell. At 18 h p.i., coverslips were ﬁxed in PBS
containing 1% formaldehyde for 10 min at room temperature. Fixed
coverslipswere thenmoved to 4 °C and incubatedwithHN-1b antibody
(1:100 dilution) (Ng et al., 1989; Randall et al., 1987) ormAb F1a (1:100
dilution) in PBS containing 1% BSA. Cells were washed extensively
with PBS to remove unbound antibody and incubated with Alexa Fluor
488-conjugatedgoat anti-mouse antibody (Invitrogen, Carlsbad, CA). To
detect the internalization of PIV-5 HN, some coverslips were treated
with 100 μg/ml cycloheximide for 4 h at 37 °C in DMEM containing 2%
FBS. Following cycloheximide treatment, cells were ﬁxed and treated as
described above. Coverslipsweremounted on glass slides using Prolong
Gold (Invitrogen) and viewed using anAxiovert 200 Mmicroscopewith
Apotome (Zeiss, Thornwood, NY). Images were collected using an
AxioCam digital camera and Zeiss Axiovision software.
Flow cytometry
Monolayers of CV-1 cells were infected with PIV-5 at a MOI of 3
pfu/cell in triplicate in 6 well plates and 18 h p.i. were ﬁxed in PBS
containing 1% formaldehyde. Plates were then moved to 4 °C and
incubated with either a polyclonal HN antibody, mAb HN-1b, or mAb
F1a, as indicated, in PBS containing 1% BSA for 1 h. Monolayers were
washed extensively with PBS to remove unbound antibody and then
incubated with a ﬂuoroscein-isothiocyanate-conjugated secondary
antibody. Cells were washed again with PBS and resuspended in PBS
containing 0.5% formaldehyde. The ﬂuorescence intensity of 10,000
cells was determined using a FACSCalibur ﬂow cytometer (Becton
Dickinson, Franklin Lakes, NJ). Cells that required cycloheximide
treatment were prepared as described above, followed by ﬁxation.
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MBDK cells were infected with PIV-5 as described above at an MOI
of 0.01 pfu/cell in 6 cm dishes. Mediumwas removed and assayed for
viral titer at varying time points. For plaque assays BHK-21F cells were
infected with dilutions of PIV-5 in DMEM containing 1% BSA for 1 h at
37 °C. Following infection, monolayers were overlaid with medium
containing DMEM, 2% FBS, and 1% low-melting temperature agarose.
Upon solidiﬁcation, dishes were returned to 37 °C and incubated for
96 h, at which time the agarose was removed and the cells were ﬁxed.
Plaques were visualized following a 10 min Giemsa stain treatment.
Viral ﬁtness competition assay
The relative ﬁtness of mutant viruses compared to wt PIV-5 was
determined using a virus competition assay. MDBK cells were infected
at a mutant to wt ratio of 20:1 (MOI of 0.02–0.001 PFU/cell,
respectively) as described above. At 72 h p.i., the cell medium was
collected, clariﬁed by low speed centrifugation to remove cell debris,
and used to infect a fresh population of MDBK cells at an MOI of 0.01
PFU/cell. This was repeated for a total of four cycles. To determine the
abundance of mutant virus compared to wt, viral RNA was isolated
from the cell supernatant using the QIAamp Viral RNA Mini Kit
(Qiagen, Valencia, CA). Viral RNA was reverse transcribed and
ampliﬁed using SuperScript III One-Step PCR System (Invitrogen),
with the primer 1 (5’-CCAATTGTAGAGGTAGAGCGAC-3’) and primer
2 (5’-GAAAGCTACAAGGAGAGCAGGAAAC-3’). Resulting amplicons
were sequenced using primer 1 using an Applied Biosystems 3100-
Avant automated DNA sequencer.
To determine the ratio of mutant to wt RNA in a sample by com-
paring chromatogram peak heights, a sequencing standard curve was
developed. For each mutant, this was accomplished by mixing mutant
and wt plasmids together in the following ratios: 20:1, 10:1, 5:1, 2:1,
1:1, 1:2, 1:5, and 1:10. These plasmid mixtures were sequenced using
primer 1 and the heights of the chromatogram peaks at the mutation
site were measured. The ratio of the measured peak heights for the
sequencedmutant versuswt plasmidswas plotted against the original
ratio of the plasmid mixture. A best-ﬁt line was obtained to describe
the resulting curve. The equation of this line was used to determine
the ﬁnal mutant to wt ratio in the viral competition assay.
The alternative ﬁtness assay was approached using a variation of
the standardization method described above. MDBK cells were
infected as described with a mutant to wt ratio of 100:1. At 5, 6, 7,
and 8 days p.i., medium (140 μl) was removed from the infected
dishes and subjected to vRNA puriﬁcation, RT-PCR, and sequencing as
described above.
To ensure that there were no sequence reversions back to wt,
MDBK cells were also infected with wt PIV-5, PIV-5 HN E37D, or PIV-5
HN E37K alone and monitored as described above.
PIV-5 virion puriﬁcation and labeling
MDBK cells in 10 cm dishes were infected at an MOI of 0.01 PFU/
cell with PIV-5. Six days p.i., the cell supernatant was cleared of
cellular debris by low speed centrifugation. The clariﬁed supernatant
was centrifuged in a Ti45 rotor at 38,500 rpm for 45 min at 4 °C in an
Optima L-80 XP Ultracentrifuge (Beckman Coulter, Brea, CA). The
pelleted virus was resuspended in 1 ml NTE buffer (10 mM Tris–HCl,
pH 8.0, 0.5 M NaCl, 1 mM EDTA) and overlaid on a 15–60% sucrose
gradient made with NTE. The ﬁnal volume of the gradient was 36 ml.
The gradients were centrifuged in a SW32 rotor at 24,000 rpm for 1 h
at 4 °C. The bands that contained puriﬁed virus were collected with a
syringe, diluted in NTE buffer, and pelleted in a Ti70 rotor at
40,000 rpm for 45 min at 4 °C. The pelleted, puriﬁed virus was
resuspended in 500 μl of NTE, ﬂash frozen, and stored at−80 °C. The
concentration of the puriﬁed virus was determined by BCA assay(Pierce, Rockford, IL) using BSA as a standard. The protein composi-
tion of the puriﬁed virus was veriﬁed by SDS-PAGE followed by
Coomassie blue R250 staining and silver staining.
For [35S]-labeled puriﬁed virus, MDBK cells were infected as above.
Forty-eight hours p.i., the medium was removed and replaced with a
medium that contained 20% of the normal amount of methionine
found in DMEM together with [35S]-methionine (50 μCi/ml). Follow-
ing 2 days of incubation in the [35S]-labeled medium, the plates were
supplemented with methionine in order to bring the ﬁnal concentra-
tion of methionine in the medium to the level in complete DMEM.
After an additional 48 h of incubation at 37 °C, the supernatant was
harvested and virus was puriﬁed as described above.
Neuraminidase activity
Determination of neuraminidase activity of puriﬁed virions was
performed essentially as described by Warren (1959). Puriﬁed virus
(20 μg) was incubated in glass tubes in buffer containing 80 mM
sodium acetate, pH 4.5 and 80 μg of N-acetylneuraminyl lactose (Sigma,
St. Louis, MO) in a ﬁnal volume of 500 μl for 1.5 h at 37 °C. Periodate
was then added to a ﬁnal concentration of 4 mM and incubated for
30 min at 37 °C. Following incubation, 80 μl of a 2% (w/v) sodium
arsenite solution was added and the tubes rocked gently until the
yellow color disappeared. Eight hundred microliters of 0.1 M thiobar-
bituric acid was added to the sample and boiled for 10 min in a water
bath. The reactions were transferred to ice immediately, and 2 ml of
acidiﬁed butanol was added to the sample. Tubes were centrifuged at
1500 rpm for 10 min and the butanol phase was extracted and
absorbance read at 549 nm.
Hemadsorption
Monolayers of CV-1 cells in 24 well plates were infected in
sextuplicate with PIV-5 as described above at an MOI of 10 PFU/cell.
At 18 h p.i., cells were washed gently three times with ice cold PBS
containing calcium and magnesium (PBS+). Infected cells were then
incubated at 4 °C for 30 min with a solution of 1% chicken red blood
cells (RBCs) suspended in PBS+. Following receptor binding, cells
werewashed gently ﬁve timeswith ice cold PBS+to remove unbound
RBCs. Bound RBCs were lysed in 200 μl of lysis buffer (17 mM Tris–
HCl, 0.145 M NH4Cl). The absorbance of the lysed RBCs was read on a
Spectramax M5 (Molecular Devices, Sunnyvale, CA) at an absorbance
of 410 nm. The pH of the PBS+was adjusted to either pH 5.0 or pH 7.0
depending on the experiment.
Syncytia formation
BHK-21F cells were transfected as described above using 1 μg each
of pCAGGS-HN and pCAGGS-F plasmid. At 18 h post-transfection (p.t.),
cells were ﬁxed and syncytia visualized using a Hema3 stain (Fisher
Scientiﬁc, Pittsburgh, PA) according to the manufacturer's instructions.
Micrographs were taken using an inverted phase-contrast microscope
(Diaphot, Nikon, Melville, NY) connected to a digital camera (DCS 760,
Kodak, Rochester, NY).
Luciferase reporter assay
Vero cell monolayers in 6 well plates were transfected in triplicate
with 1 μg each of pCAGGS-HN, pCAGGS-F, and pT7-luciferase, a plasmid
that expresses ﬁreﬂy luciferase under the control of the T7 promoter. At
18 h p.t., BSR-T7/5 cells that express T7 polymerase were overlaid onto
the Vero cells and incubated for 6 h at 37 °C. Cells were then lysed in 2X
Reporter Lysis Buffer (Promega) and clariﬁed by centrifugation. The
luciferase activity of each sample was determined by adding 150 μl of
lysate to 150 μl of luciferase assay substrate in an Lmax luminescence
microplate reader (Molecular Devices, Sunnyvale, CA).
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PIV-5-infected CV-1 cells in 6 cm dishes were labeled as described
above and then incubated for 1.5 h. Cells were lysed in 750 μl of MNT
buffer (20 mM morpholino-ethanesulfonic acid, 30 mM Tris, 100 mM
NaCl; pH 5.0) containing 1% Triton X-100 and 1% aprotinin. Lysates
were clariﬁed as described above and the supernatant layered over a
continuous 7.5–22.5% wt/vol sucrose gradient made in MNT buffer
containing 0.1% Triton X-100 that overlaid a 0.75 ml 60% sucrose
cushion. The ﬁnal volume of the gradient was 12 ml. The gradients
were centrifuged at 37,000 rpm for 19 h at 20 °C. Fractions (0.5 ml)
were collected using an Auto Densi-Flow fraction collector (LabConco,
Kansas City, MO). Alternate fractions, beginning with the top fraction,
were prepared for immunoprecipitation by the addition of 2X RIPA
buffer containing protease inhibitors, iodoacetamide, and PMSF.
Proteins were immunoprecipitated as described above using a
polyclonal HN antibody, followed by protein A sepharose treatment
and RIPAwashes. Proteins were separated using an 8% acrylamide gel.
Blue native PAGE
Blue native PAGEwas performed essentially as described byWittig
et al. (2006). Brieﬂy, 20 μg of puriﬁed virions were resuspended in a
ﬁnal volume of 33 μl of solubilization buffer A. Detergents were added
in ﬁnal concentrations of 1.2% for digitonin or 0.6% for Triton X-100.
Virions were solubilized for 20 min at 37 °C after which glycerol was
added at a ﬁnal concentration of 15% and Coomassie blue G-250 was
added at a ﬁnal concentration of 0.05%. Solubilized viral proteins were
loaded on a 4–13% native acrylamide gel. Separated proteins were
transferred to a polyvinylidene ﬂuoride membrane in the presence of
0.01% SDS. Proteins were detected by the addition of a polyclonal HN
antibody and a Cy5-conjugated goat anti-rabbit antibody followed by
visualization using a Fuji FLA-5100.
Puriﬁcation of HN stalk
Plasmids expressing residues 34–115 of the PIV-5 HN protein
fused to an N-terminal His-Tag were constructed using the pET30 Ek/
LIC Vector Kit (EMD Chemicals, Gibbstown, NJ) according to the
manufacturer's instructions. pCAGGS-HN and its corresponding
mutant plasmids were used to generate the insert into the pET30
plasmid. The nucleotide sequence of all plasmids insert segments was
veriﬁed by DNA sequencing.
Origami 2 cells (EMD Chemicals, Gibbstown, NJ) carrying pET30-
HNstalk from an overnight culture were diluted 1:20 and grown in M9
minimal medium supplemented with kanamycin (30 μg/ml) and
tetracycline (12.5 μg/ml) until the OD600 was between 0.5 and 0.6. At
that point, IPTGwas added at aﬁnal concentration of 1 mMand the cells
were incubated at 37 °C for an additional 4 h. Cells were pelleted using
centrifugation and frozen at −20 °C. Pellets were thawed and
resuspended in buffer (10 mM Tris–HCl pH 7.4, 2.5 mM MgCl2,
0.5 mM CaCl2) containing 1% Triton X-100 and protease inhibitors and
incubated at 25 °C for 30 min. DNase was added and the lysate was
incubated an additional 30 min at 25 °C, followed by sonication on ice
for 2.5 min using a probe sonicator. Lysates were clariﬁed using a JA-14
rotor for 30 min at 10,000 rpm at 4 °C. The supernatant was ﬁltered
using a 0.45 μm ﬁlter and brought to a ﬁnal concentration of 50 mM
Tris–HCl pH 8.0 and 250 mM NaCl. HN stalk was puriﬁed from the
supernatant by passage over a pre-equilibrated Ni-NTA (Qiagen,
Valencia, CA) column using the manufacturer's instructions. The
puriﬁed protein was concentrated by centrifugal ultraﬁltration (Milli-
pore, Billerica, MA) and further puriﬁed by size-exclusion chromatog-
raphy on a Pharmacia Superdex-200 column (10 × 300 mm) pre-
equilibrated with a buffer of 50 mM Tris–HCl pH 7.4 and 250 mMNaCl.
The column was calibrated with a gel ﬁltration standard (Bio-Rad,
Hercules, CA). Protein concentration was determined by measuringabsorbance at 280 nmusing anextinction coefﬁcient of 8480 M−1 cm−1
based on predictions obtained from the ExPASy server (Swiss Institute
of Bioinformatics, Lausanne, Switzerland).
Circular dichroism
Puriﬁed protein was diluted in buffer (10 mM sodium phosphate,
pH 7.4). The CD spectra was obtained using a Jasco model 715
spectropolarimeter (Easton, MD) using a quartz cuvette with a path
length of 2.0 mm. Data were collected every 0.2 nmwith a bandwidth
of 2.0 nm and a response time of 2 s. The sensitivity was set at 100
mdeg. Baseline scans of buffer were subtracted from the sample
spectra. Each spectrum represents the average of ﬁve reads. α-helical
content was determined using the CDSSTR program (Johnson, 1999;
Sreerama and Woody, 2000).
Differential scanning ﬂuorimetry
Differential scanning ﬂuorimetry (DSF) was carried out essentially
as described by Niesen et al. (2007). Puriﬁed HN stalk at a ﬁnal
concentration of 60 μM was diluted in a buffer containing 50 mM
Tris–HCl pH 7.4 and 250 mM NaCl together with SYPRO Orange
(Invitrogen, Carlsbad, CA) at a ﬁnal concentration of 50×. The ﬁnal
volume of the reaction was 50 μl. SYPRO Orange was supplied as a
5000× solution in 100% (v/v) dimethyl sulfoxide (DMSO) and was
diluted 1:100 in buffer before addition to the reaction in order to
prevent high concentrations of DMSO from contacting and damaging
the protein. The reactions were prepared in triplicate in iQ 96-well
PCR plates (Bio-Rad, Hercules, CA). The melting point of the protein
was determined using a Bio-Rad iCycler iQ Real-Time PCR Detection
System (Bio-Rad, Hercules, CA) using a program of 3 min at 25 °C,
followed by a temperature scan from 25 to 95 °C at 1 °C/min. The
minimum of the negative ﬁrst derivative of the ﬂuorescence curve
was used to determine the melting point of each protein.
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